"The portfolio demonstrates strong resilience with RAROC above target levels. However, concentration risk in manufacturing requires immediate attention. The AI models suggest that diversification into technology and healthcare sectors, combined with dynamic pricing adjustments, could improve RAROC by 50-75 basis points while reducing overall portfolio risk by 15%. Current stress testing indicates adequate capital buffers, but monitoring of manufacturing sector developments is crucial for maintaining performance."